EUVIMEDEUVIMED entdecken
Fallbericht

A MAZ::NCOA2 Subcutaneous Small Round Cell Sarcoma of Infancy With Diffuse S100 / SOX10 Positivity: A Novel Entity

Huiyao Chen iD, Pu Zhang, Lingli Zhou iD

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70034 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Huiyao Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Nuclear Receptor Coactivator 2, SOXE Transcription Factors, S100 Proteins, Sarcoma, Small Cell. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small round cell sarcomas (SRCSs) constitute a heterogeneous group of high‐grade tumors with a poor prognosis, predominantly affecting children and young adults. According to the 2020 WHO Soft Tissue Tumor classification, SRCSs are categorized into Ewing sarcoma, round cell sarcoma with EWSR1 ‐non‐ETS fusions, CIC ‐rearranged sarcoma, and sarcoma with BCOR genetic alterations. Herein, we report a case of a 10‐month‐old boy presenting with a progressively enlarging left lumbar mass. Histopathological examination revealed a well‐demarcated lesion composed of small, round to oval cells with scant cytoplasm and mildly irregular nuclei. Immunohistochemical staining demonstrated strong, diffuse positivity for S100 and SOX10, indicating neurocristic differentiation. Next‐generation sequencing identified an in‐frame fusion between MAZ exon 3 on chromosome 16 and NCOA2 exon 12 on chromosome 8. Fluorescence in situ hybridization (FISH) confirmed a break‐apart signal at the NCOA2 locus. To the best of our knowledge, this represents the first documented instance of an NCOA2 rearrangement involving MAZ in SRCSs. This case broadens the molecular spectrum of SRCSs, highlights the importance of incorporating molecular techniques into diagnostic workflows, and may have implications for future diagnostic and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Coactivator 2SOXE Transcription FactorsS100 ProteinsSarcoma, Small CellTranscription FactorsDNA-Binding ProteinsSoft Tissue NeoplasmsHumansMaleInfantOncogene Proteins, Fusion

Stichwörter der Autor:innen

MAZNCOA2S100SOX10small round cell sarcomasubcutaneous

Substanzen

NCOA2 protein, humanNuclear Receptor Coactivator 2SOXE Transcription FactorsS100 ProteinsSOX10 protein, humanTranscription FactorsDNA-Binding ProteinsOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Huiyao Chen, Lingli Zhou

Zitieren

APA

Chen, H., Zhang, P., & Zhou, L. (2025). A MAZ::NCOA2 Subcutaneous Small Round Cell Sarcoma of Infancy With Diffuse S100 / SOX10 Positivity: A Novel Entity. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70034

Vancouver

Chen H, Zhang P, Zhou L. A MAZ::NCOA2 Subcutaneous Small Round Cell Sarcoma of Infancy With Diffuse S100 / SOX10 Positivity: A Novel Entity. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70034

BibTeX
@article{Chen2025,
  author = {Chen, Huiyao and Zhang, Pu and Zhou, Lingli},
  title = {A MAZ::NCOA2 Subcutaneous Small Round Cell Sarcoma of Infancy With Diffuse S100 / SOX10 Positivity: A Novel Entity},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70034}
}
Kostenlos starten →